| Synonyms: | |
| Status: | Approved (2020) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | Y64GQ0KC0A |
Pharmacology
| Primary Target | |
|---|---|
| Insulin-like growth factor I receptor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Graves Ophthalmopathy | 4 | D049970 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Scleroderma, Diffuse | 1 | D045743 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1036734-93-6 |
| ChEMBL | CHEMBL1743079 |
| FDA SRS | Y64GQ0KC0A |
| Guide to Pharmacology | 10612 |
CONTENTS